Showing results (111-120 of 276) with videos related to

Sort By:
Pageof 28
Neurology|September 26, 2001
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonusS J Frucht, E D Louis, C Chuang, et al.
Life Sciences|July 11, 1983
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosineA Reches, M N Hassan, V R Jackson, et al.
Neurology|February 1, 1984
Pergolide therapy for Parkinson's disease: neurobehavioral changesY Stern, R Mayeux, J Ilson, et al.
The Laryngoscope|February 1, 1988
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)A Blitzer, M F Brin, S Fahn, et al.
Annals of Neurology|December 1, 1986
Correlates of early disability in Huntington's diseaseR Mayeux, Y Stern, A Herman, et al.
Brain Research|November 18, 1985
Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockadeA Reches, H R Wagner, V Jackson-Lewis, et al.
Neurology|February 1, 1997
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's diseaseE D Louis, L A Klatka, Y Liu, et al.
Archives of Neurology|July 1, 1996
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patientsS L Pullman, P Greene, S Fahn, et al.
Brain Research|January 2, 1989
Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidenceJ L Cadet, M Katz, V Jackson-Lewis, et al.
Advances in Neurology|January 1, 1986
Biotin-responsive encephalopathy with myoclonus, ataxia, and seizuresS Bressman, S Fahn, M Eisenberg, et al.
Pageof 28